Similar companies
| Company | Stocktwits Subscribers | |
|---|---|---|
 |
AmgenAMGN |
14,290 0% |
 |
Gilead SciencesGILD |
77,146 0% |
 |
Catalyst PharmaceuticalsCPRX |
15,582 0% |
 |
Inovio PharmaceuticalsINO |
93,165 0% |
 |
Anavex Life SciencesAVXL |
20,964 0.1% |
Month over Month
Subscribing Stocktwits Users
| Nov 2024 | 17,036 | |
| Oct 2024 | 17,055 | |
| Sep 2024 | 17,060 | |
| Aug 2024 | 17,072 | |
| Jul 2024 | 17,073 |
How many users are following Editas Medicine on StockTwits?
The interest in Editas Medicine on StockTwits is decent, with a following of 16,855 investors.
Analyzing Stocktwits Subscribers, how is Editas Medicine performing compared to its industry peers?
Editas Medicine underperforms its industry peers when it comes to Stocktwits Subscribers, ranking in the 11th percentile.
What has been the change in Editas Medicine's StockTwits followers over the past month?
There has been no meaningful change in the number of followers in the last month.
What is StockTwits?
StockTwits is a social media platform designed specifically for the investing community. It enables investors and traders to share market insights, strategies, and real-time news updates. Essentially, it's a specialized network for financial market discussions, often characterized by brief, tweet-like posts.
Why is it important for Editas Medicine investors to monitor its StockTwits followers?
For investors in Editas Medicine, tracking the number of followers on StockTwits can be highly beneficial. The platform's follower count offers a direct gauge of investor interest and sentiment surrounding Ford. An increasing follower count typically suggests growing investor attention and can be an indicator of rising market enthusiasm or concern about the company's prospects. This data can provide investors with valuable insights into market trends, potential shifts in investor behavior, and broader perceptions of Ford in the investment community.
Sign up and get more insights on Editas Medicine.
